LIGAND PHARMACEUTICALS INCORPORATED

(NASDAQ:LGND)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 71,112 29,177 59,543 76,812
Restricted Cash
Marketable Securities 55,819 30,685 17,596
Accounts Receivable
Loans Receivable
Other Receivable 10,416
Receivables 10,416
Raw Materials
Work in Progress
Purchased Components
Finished Goods
Other Inventories
Inventories Adjustments and Allowances
Inventories
Prepaid Expenses 1,252
Current Deferred Income Taxes
Other Current Assets 14,853 11,116 3 15,535
Total Current Assets 85,965 96,112 101,899 109,943
Land and Improvements
Building and Improvements
Machinery Furniture and Equipment 37,090 40,577
Construction in Progress
Other Fixed Assets 36,964
Total Fixed Assets 37,090 36,964 40,577
Gross Fixed Assets 1,687 37,090 36,964 40,577
Accumulated Depreciation and Depletion 35,066 34,873 37,712
Net Fixed Assets 1,687 2,024 2,091 2,865
Intangibles
Cost in Excess
Non Current Deferred Income Taxes
Other Non Current Assets 59,539 61,887 62,275 60,470
Total Non Current Assets 61,226 63,911 64,366 63,335
Total Assets 147,191 160,023 166,265 173,278
Liabilities
Current Liabilities
Accounts Payable 38,197 10,290 10,760 12,682
Notes Payable 716
Short Term Debt 978 1,238 1,528
Accrued Expenses
Accrued Liabilities 22,698 21,698 24,327
Deferred Revenues 1,964 1,964 1,964
Current Deferred Income Tax Liabilities
Other Current Liabilities 12,788 8,682 8,651 10,467
Total Current Liabilities 51,701 44,612 44,311 50,968
Non Current Liabilities
Long Term Debt 266 403 627
Capital Lease Obligations
Deferred Income Tax Liabilities
Other Non Current Liabilities 81,191 96,124 97,017 92,568
Minority Interest Liabilities
Preferred Securities of Subsidiary Trust Liabilities
Preferred Equity Outside Stock Equity
Total Non Current Liabilities 132,892 141,002 141,731 144,163
Total Liabilities 81,191 96,390 97,420 93,195
Shareholders' Equity
Preferred Stock Equity
Common Stock Equity 1,954 19,021 24,534 29,115
Common Par 101 101 101
Additional Paid in Capital 652,956 652,055 651,038
Cumulative Translation Adjustment
Retained Earnings -591,874 -585,445 -581,512
Treasury Stock -42,134 -42,134 -40,521
Other Equity Adjustments -28 -43 9
Total Capitalization 1,954 19,287 24,937 29,742
Cash Flow -2,847 4,942 284,303
Working Capital 34,264 51,500 57,588 58,975
Free Cash Flow -5,697 -1,537 -40,585
Invested Capital 1,954 19,287 24,937 29,742
Total Equity 1,954 19,021 24,534 29,115
Total Liabilities and Stock Equity 134,846 160,023 166,265 173,278